Cargando…
Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities
Lupus nephritis (LN) is a frequent and serious complication of systemic lupus erythematosus (SLE), impairing patients’ quality of life and significantly increasing mortality. Despite optimizing the use of conventional immunosuppressants and other biological drugs, its management remains unsatisfacto...
Autores principales: | Neves, Ana, Viveiros, Luísa, Venturelli, Veronica, Isenberg, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348374/ https://www.ncbi.nlm.nih.gov/pubmed/37456804 http://dx.doi.org/10.2147/RRU.S385836 |
Ejemplares similares
-
Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis
por: Zhou, Xue, et al.
Publicado: (2022) -
Interventions to Improve Quality of Life in Multiple Sclerosis: New Opportunities and Key Talking Points
por: Faraclas, Erin
Publicado: (2023) -
A new promising biological agent for refractory lupus nephritis: Telitacicept
por: Liu, Shuangyan, et al.
Publicado: (2023) -
Very delayed lupus nephritis: a report of three cases and literature review
por: Alexandre, André R, et al.
Publicado: (2018) -
Impact of pre-transplant time on dialysis on survival in patients with lupus nephritis
por: Ntatsaki, Eleana, et al.
Publicado: (2018)